These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

763 related items for PubMed ID: 15612981

  • 81. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K, Isogai K, Horisawa S, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M, Takahashi K, Hirano T.
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [Abstract] [Full Text] [Related]

  • 82. Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results.
    Borrows R, Loucaidou M, Van Tromp J, Singh S, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Transplant Proc; 2005 May; 37(4):1792-4. PubMed ID: 15919468
    [Abstract] [Full Text] [Related]

  • 83. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
    Lee H, Lee S, Jeon JS, Kwon SH, Noh H, Han DC, Yun S, Song D.
    Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
    [Abstract] [Full Text] [Related]

  • 84. Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.
    Ferraresso M, Belingheri M, Ginevri F, Murer L, Dello Strologo L, Cardillo M, Parodi A, Ghirardo G, Guzzo I, Innocente A, Ghio L.
    Pediatr Transplant; 2014 Jun; 18(4):350-6. PubMed ID: 24802342
    [Abstract] [Full Text] [Related]

  • 85. Induction with basiliximab in renal transplantation.
    Ferrer F, Machado S, Alves R, Macário F, Bastos C, Roseiro A, Mota A.
    Transplant Proc; 2010 Mar; 42(2):467-70. PubMed ID: 20304166
    [Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89. Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody.
    Gonwa TA, Mai ML, Smith LB, Levy MF, Goldstein RM, Klintmalm GB.
    Clin Transplant; 2002 Apr; 16(2):144-9. PubMed ID: 11966785
    [Abstract] [Full Text] [Related]

  • 90. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy.
    Anil Kumar MS, Heifets M, Fyfe B, Saaed MI, Moritz MJ, Parikh MH, Kumar A.
    Transplantation; 2005 Sep 27; 80(6):807-14. PubMed ID: 16210969
    [Abstract] [Full Text] [Related]

  • 91. Low-dose steroid maintenance for renal transplant recipients.
    Kishikawa H, Nishimura K, Soda T, Yamanaka K, Hirai T, Kyo M, Takeda M, Fujisawa M, Kokado Y, Ichikawa Y.
    Transplant Proc; 2010 Dec 27; 42(10):4030-2. PubMed ID: 21168618
    [Abstract] [Full Text] [Related]

  • 92. Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine.
    Cransberg K, Bouts AH, Cornelissen EA, Lilien MR, Van Hoeck KJ, Hop WC, Nauta J.
    Transplantation; 2008 Nov 15; 86(9):1199-205. PubMed ID: 19005400
    [Abstract] [Full Text] [Related]

  • 93. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
    Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo AA, Murray BM, Tornatore KM, Blessios GA, Venuto RC.
    Nephrol Dial Transplant; 2012 May 15; 27(5):2077-83. PubMed ID: 22058172
    [Abstract] [Full Text] [Related]

  • 94. Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe.
    Loucaidou M, Borrows R, Cairns T, Griffith M, Hakim N, Palmer A, Papalois V, Taube D, McLean AG.
    Transplant Proc; 2005 May 15; 37(4):1795-6. PubMed ID: 15919469
    [Abstract] [Full Text] [Related]

  • 95. Corticosteroid reduction with tacrolimus (CORRETA) TRIAL: a prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus (Prograf) and mycophenolate mofetil (Cellcept) immunosuppression regimen in kidney transplant recipients: interim analysis.
    Garcia VD, Carvalho DB, Goncalves RT, Cavalcanti RL, Campos HH, Abbud-Filho M, Lobao-Neto AA.
    Transplant Proc; 2008 Apr 15; 40(3):689-92. PubMed ID: 18454988
    [Abstract] [Full Text] [Related]

  • 96. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
    Gruttadauria S, Cintorino D, Piazza T, Mandala L, Doffria E, Musumeci A, Di Trapani G, Arcadipane A, Scianna G, Spada M, Verzaro R, Volpes R, Vizzini G, Palazzo U, Minervini M, Marsh JW, Marcos A, Gridelli B.
    Transplant Proc; 2006 May 15; 38(4):1106-8. PubMed ID: 16757278
    [Abstract] [Full Text] [Related]

  • 97. Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.
    Höcker B, Weber LT, Bunchman T, Rashford M, Tönshoff B, Tricontinental MMF Suspension Study Group.
    Pediatr Transplant; 2005 Aug 15; 9(4):504-11. PubMed ID: 16048604
    [Abstract] [Full Text] [Related]

  • 98. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M, Margarit C, Chavez R, Ortega J, Charco R, Iglesias J.
    Transplant Proc; 2002 Aug 15; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract] [Full Text] [Related]

  • 99. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.
    Jain A, Sharma R, Ryan C, Tsoulfas G, Orloff M, Abt P, Kashyap R, Batzold P, Sauberman L, Safadjou S, Graham M, Bozorgzadeh A.
    Liver Transpl; 2008 Feb 15; 14(2):202-9. PubMed ID: 18236395
    [Abstract] [Full Text] [Related]

  • 100. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.
    De Paolis P, Favarò A, Piola A, Martini F, Cristiana G, Agrati C, Iappelli M, Di Giulio S.
    Transplant Proc; 2011 May 15; 43(4):1013-6. PubMed ID: 21620039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.